Potassium Iodide – An Opportunity Awaiting to be Tapped

April 14, 2026
Potassium iodide (KI) has emerged as one of the most critical medical countermeasures in the event of radioactive exposure, particularly during nuclear accidents or radiological emergencies. Its demand is surging, driven by high iodine deficiency risks affecting over 16 crore people, alongside rising pharmaceutical, agricultural, and nuclear safety needs.